 |
2-Chloro-N6–(3-iodobenzyl)adenosine-5′-N-methyluronamide |
|---|---|
| Trade Name | |
| Orphan Indication | Hepatocellular Carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2012-02-17 00:00:00 |
| Sponsor | Can-Fite BioPharma Ltd.;10 Bareket Street, P. O. Box 7537;Petah-Tikva |
